Fenofibrate attenuates hyperhomocysteinemia-potentiated thrombosis by restoring platelet fatty acid β-oxidation
Open Access
- 6 June 2026
- journal article
- Published by Elsevier in Redox Biology
- Vol. 95, 104250
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82070462)
- National Natural Science Foundation of China (82300327)
- National Natural Science Foundation of China (82203172)
This publication has 47 references indexed in Scilit:
- Not all fibrates are made equal: Learning from biology and clinical trialsAtherosclerosis, 2025
- Phospholipid-derived lysophospholipids in (patho)physiologyAtherosclerosis, 2024
- Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin α2β1Cell Metabolism, 2024
- PKM2-dependent metabolic reprogramming in CD4+ T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosisJournal of Molecular Medicine, 2018
- Platelet Count Affects Efficacy of Folic Acid in Preventing First StrokeJACC, 2018
- Mapping the Human Platelet Lipidome Reveals Cytosolic Phospholipase A2 as a Regulator of Mitochondrial Bioenergetics during ActivationCell Metabolism, 2016
- Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in miceHepatology, 2016
- Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in ChinaJAMA, 2015
- Platelets: Production, Morphology and Ultrastructure2012
- The gray platelet syndrome: Clinical spectrum of the diseaseBlood Reviews, 2007